Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Safety and efficacy of pomalidomide, dexamethasone and pegylated liposomal doxorubicin for patients with relapsed or refractory multiple myeloma.
Journal: British journal of haematology
Published: May 17, 2017
A phase 3 trial of armodafinil for the treatment of cancer-related fatigue for patients with multiple myeloma.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: May 27, 2014
A phase 2 study of pegylated liposomal doxorubicin, bortezomib, dexamethasone and lenalidomide for patients with relapsed/refractory multiple myeloma.
Journal: Leukemia
Published: February 23, 2012
Showing 1-3 of 3
Last Updated: 09/26/2026